Literature DB >> 12631663

Increased rectal mucosal expression of interleukin 1beta in recently acquired post-infectious irritable bowel syndrome.

K-A Gwee1, S M Collins, N W Read, A Rajnakova, Y Deng, J C Graham, M W McKendrick, S M Moochhala.   

Abstract

BACKGROUND AND AIMS: Chronic bowel disturbances resembling irritable bowel syndrome (IBS) develop in approximately 25% of patients after an episode of infectious diarrhoea. Although we have previously shown that psychosocial factors operating at the time of, or prior to, the acute illness appear to predict the development of post-infectious IBS (PI-IBS), our finding of an increased inflammatory cell number in the rectum persisting for at least three months after the acute infection suggested that there is also an organic component involved in the development of PI-IBS. To evaluate this further, we measured expressions of interleukin 1beta (IL-1beta) and its receptor antagonist (IL-1ra) in these patients to provide additional evidence that the pathogenesis of PI-IBS is underpinned by an inflammatory process.
METHODS: Sequential rectal biopsy samples were prospectively obtained during and three months after acute gastroenteritis, from eight patients who developed post-infectious IBS (INF-IBS) and seven patients who returned to normal bowel habits after acute gastroenteritis (infection controls, INF-CON). Eighteen healthy volunteers who had not suffered from gastroenteritis in the preceding two years served as normal controls (NOR-CON). IL-1beta and IL-1ra gene expressions were assayed by reverse transcriptase-polymerase chain reaction, and their levels of expression were quantitated by optical densitometry after electrophoresis on agarose gel.
RESULTS: INF-IBS patients exhibited significantly greater expression of IL-1beta mRNA in rectal biopsies than INF-CON patients both during and three months after acute gastroenteritis. Moreover, IL-1beta mRNA expression had increased in biopsies taken from INF-IBS patients at three months after the acute infection but no consistent change was observed in INF-CON patients. IL-1beta mRNA expression of INF-IBS patients at three months post gastroenteritis was significantly greater than NOR-CON whereas that of INF-CON patients was not significantly different from NOR-CON. Despite these differential changes in IL-1beta mRNA expression, no significant changes were observed in IL-1ra mRNA expression among the three groups.
CONCLUSIONS: These findings indicate that those patients who develop IBS post infection exhibit greater IL-1beta mRNA expression, both during and after the infection, compared with individuals who do not develop PI-IBS. We conclude that such patients may be susceptible to inflammatory stimuli, and that inflammation may play a role in the pathogenesis of PI-IBS.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12631663      PMCID: PMC1773606          DOI: 10.1136/gut.52.4.523

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  22 in total

1.  The putative role of inflammation in the irritable bowel syndrome.

Authors:  S M Collins; T Piche; P Rampal
Journal:  Gut       Date:  2001-12       Impact factor: 23.059

2.  Activation of the mucosal immune system in irritable bowel syndrome.

Authors:  Vinton S Chadwick; Wangxue Chen; Dairu Shu; Barbara Paulus; Peter Bethwaite; Andy Tie; Ian Wilson
Journal:  Gastroenterology       Date:  2002-06       Impact factor: 22.682

3.  Increased risk of irritable bowel syndrome after bacterial gastroenteritis: cohort study.

Authors:  L A Rodríguez; A Ruigómez
Journal:  BMJ       Date:  1999-02-27

4.  Persistent intestinal neuromuscular dysfunction after acute nematode infection in mice.

Authors:  G Barbara; B A Vallance; S M Collins
Journal:  Gastroenterology       Date:  1997-10       Impact factor: 22.682

5.  Stress-induced enhancement of colitis in rats: CRF and arginine vasopressin are not involved.

Authors:  M Gué; C Bonbonne; J Fioramonti; J Moré; C Del Rio-Lachèze; C Coméra; L Buéno
Journal:  Am J Physiol       Date:  1997-01

6.  The role of CD4+ lymphocytes in the susceptibility of mice to stress-induced reactivation of experimental colitis.

Authors:  B S Qiu; B A Vallance; P A Blennerhassett; S M Collins
Journal:  Nat Med       Date:  1999-10       Impact factor: 53.440

7.  Role of immunologic factors and cyclooxygenase 2 in persistent postinfective enteric muscle dysfunction in mice.

Authors:  G Barbara; R De Giorgio; Y Deng; B Vallance; P Blennerhassett; S M Collins
Journal:  Gastroenterology       Date:  2001-06       Impact factor: 22.682

8.  Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome.

Authors:  R C Spiller; D Jenkins; J P Thornley; J M Hebden; T Wright; M Skinner; K R Neal
Journal:  Gut       Date:  2000-12       Impact factor: 23.059

9.  Previous inflammation alters the response of the rat colon to stress.

Authors:  S M Collins; K McHugh; K Jacobson; I Khan; R Riddell; K Murase; H P Weingarten
Journal:  Gastroenterology       Date:  1996-12       Impact factor: 22.682

10.  The role of psychological and biological factors in postinfective gut dysfunction.

Authors:  K A Gwee; Y L Leong; C Graham; M W McKendrick; S M Collins; S J Walters; J E Underwood; N W Read
Journal:  Gut       Date:  1999-03       Impact factor: 23.059

View more
  98 in total

1.  East meets West: infection, nerves, and mast cells in the irritable bowel syndrome.

Authors:  S M Collins; G Barbara
Journal:  Gut       Date:  2004-08       Impact factor: 23.059

2.  Progress report.

Authors:  R C Spiller
Journal:  Gut       Date:  2004-03       Impact factor: 23.059

3.  Management of the returning traveler with diarrhea.

Authors:  Philippe P H de Saussure
Journal:  Therap Adv Gastroenterol       Date:  2009-11       Impact factor: 4.409

Review 4.  What does irritable bowel syndrome share with non-alcoholic fatty liver disease?

Authors:  Antonella Scalera; Matteo Nicola Dario Di Minno; Giovanni Tarantino
Journal:  World J Gastroenterol       Date:  2013-09-07       Impact factor: 5.742

Review 5.  Diagnosis and management of IBS.

Authors:  Sarah Khan; Lin Chang
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-10       Impact factor: 46.802

6.  High-sensitive C-Reactive Protein as a Marker for Inflammation in Irritable Bowel Syndrome.

Authors:  Keren Hod; Tamar Ringel-Kulka; Christopher F Martin; Nitsan Maharshak; Yehuda Ringel
Journal:  J Clin Gastroenterol       Date:  2016-03       Impact factor: 3.062

Review 7.  Post-infectious irritable bowel syndrome.

Authors:  Andrew W Dupont
Journal:  Curr Gastroenterol Rep       Date:  2007-10

8.  Prospective study of motor, sensory, psychologic, and autonomic functions in patients with irritable bowel syndrome.

Authors:  Michael Camilleri; Sanna McKinzie; Irene Busciglio; Phillip A Low; Seth Sweetser; Duane Burton; Kari Baxter; Michael Ryks; Alan R Zinsmeister
Journal:  Clin Gastroenterol Hepatol       Date:  2008-05-05       Impact factor: 11.382

9.  Chronic diarrhea in travelers.

Authors:  Bradley A Connor
Journal:  Curr Infect Dis Rep       Date:  2013-06       Impact factor: 3.725

10.  Bacillary dysentery as a causative factor of irritable bowel syndrome and its pathogenesis.

Authors:  L-H Wang; X-C Fang; G-Z Pan
Journal:  Gut       Date:  2004-08       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.